LEXICON PHARMACEUTICALS, INC. (LXRX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US5288723027
LEXICON PHARMACEUTICALS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 49.80 m USD |
| Gross profit | 49.53 m USD |
| Operating income | -48.91 m USD |
| EBIT | -50.34 m USD |
| Net income | -50.34 m USD |
| Diluted EPS – continuing operations | -0.14 USD |
Full history since 1999, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About LEXICON PHARMACEUTICALS, INC.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
More stocks
- Beijing Asiacom Information Technology Co.Ltd (301085.SZ)
- Changzhou Architectural Research Institute Group Co. Ltd. A (301115.SZ)
- Zhejiang Changhua Auto Parts Co Ltd (605018.SS)
- Bergman & Beving AB (BERG B.ST)
- China Shineway Pharmaceutical Group Ltd (2877.HK)
- VITZROCELL Co.Ltd (082920.KQ)
- Qingdao Tianneng Heavy Industries Co Ltd (300569.SZ)
- PennyMac Mortgage Investment Trust (PMT)
- Lian Hwa Foods Corp (1231.TW)
- JAFCO Group Co Ltd (8595.T)
- Neo Performance Materials Inc (NEO.TO)
- NUSCALE POWER Corp (SMR)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.